30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Kevin McNamara

Track

Insider profile

Currently holds a position at Chemed Corp

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 0% 8.2% 15.1%
Success rate 55% 68% 82%
Transactions
41 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
President, Chief Executive Officer, Director Chemed Corp May 22, 2001 -
Kevin McNamara's trades of Chemed Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-04 2026-05-01
US Chemed Corp (CHE)
S Sale
14,587 -37.7%
81.66
US$752,774 		14,587 -37.7% 81.66 US$752,774
2026-05-01 2026-05-01
US Chemed Corp (CHE)
PrS Proposed sale
84,139
107.21
US$4,484,662 		84,139 107.21 US$4,484,662
2026-05-01 2026-05-01
US Chemed Corp (CHE)
PrS Proposed sale
85,770
322.23
US$1,670,158 		85,770 322.23 US$1,670,158
2026-03-30 2026-03-27
US Chemed Corp (CHE)
S Sale
1,500 -1.6%
369.37
US$554,055 		1,500 -1.6% 369.37 US$554,055
2026-03-27 2026-03-27
US Chemed Corp (CHE)
PrS Proposed sale
1,500
372.57
US$558,855 		1,500 372.57 US$558,855
2026-03-13 2026-03-12
US Chemed Corp (CHE)
S Sale
2,000 -2.1%
403.18
US$806,360 		2,000 -2.1% 403.18 US$806,360
2026-03-12 2026-03-12
US Chemed Corp (CHE)
PrS Proposed sale
1,000
403.82
US$403,820 		1,000 403.82 US$403,820
2026-03-12 2026-03-12
US Chemed Corp (CHE)
PrS Proposed sale
1,000
404.79
US$404,790 		1,000 404.79 US$404,790
2025-11-25 2025-11-24
US Chemed Corp (CHE)
S Sale
2,000 -2.1%
437.55
US$875,100 		2,000 -2.1% 437.55 US$875,100
2025-11-24 2025-11-24
US Chemed Corp (CHE)
PrS Proposed sale
2,000
438.00
US$876,000 		2,000 438.00 US$876,000
2025-09-29 2025-09-26
US Chemed Corp (CHE)
PrS Proposed sale
2,000
428.55
US$857,107 		2,000 428.55 US$857,107
2025-09-29 2025-09-26
US Chemed Corp (CHE)
S Sale
3,000 -3.0%
461.28
US$1,383,840 		3,000 -3.0% 461.28 US$1,383,840
2025-09-26 2025-09-26
US Chemed Corp (CHE)
PrS Proposed sale
1,000
460.00
US$460,000 		1,000 460.00 US$460,000
2025-08-05 2025-08-05
US Chemed Corp (CHE)
PrS Proposed sale
2,000
428.73
US$857,460 		2,000 428.73 US$857,460
2025-08-05 2025-08-05
US Chemed Corp (CHE)
S Sale
2,000 -2.0%
428.55
US$857,100 		2,000 -2.0% 428.55 US$857,100
2025-05-06 2025-05-05
US Chemed Corp (CHE)
S Sale
1,500 -1.5%
576.45
US$864,675 		1,500 -1.5% 576.45 US$864,675
2025-05-05 2025-05-05
US Chemed Corp (CHE)
PrS Proposed sale
1,500
575.46
US$863,190 		1,500 575.46 US$863,190
2025-04-01 2025-03-31
US Chemed Corp (CHE)
S Sale
1,000 -1.0%
615.33
US$615,330 		1,000 -1.0% 615.33 US$615,330
2025-03-07 2025-03-06
US Chemed Corp (CHE)
S Sale
2,000 -1.9%
593.67
US$1,187,340 		2,000 -1.9% 593.67 US$1,187,340
2025-03-06 2025-03-06
US Chemed Corp (CHE)
PrS Proposed sale
2,000
593.60
US$1,187,199 		2,000 593.60 US$1,187,199
2024-11-26 2024-11-25
US Chemed Corp (CHE)
S Sale
2,000 -1.9%
572.77
US$1,145,540 		2,000 -1.9% 572.77 US$1,145,540
2024-11-25 2024-11-25
US Chemed Corp (CHE)
PrS Proposed sale
2,000
571.11
US$1,142,220 		2,000 571.11 US$1,142,220
2024-09-27 2024-09-26
US Chemed Corp (CHE)
S Sale
2,000 -1.9%
598.81
US$1,197,620 		2,000 -1.9% 598.81 US$1,197,620
2024-09-26 2024-09-26
US Chemed Corp (CHE)
PrS Proposed sale
2,000
598.75
US$1,197,505 		2,000 598.75 US$1,197,505
2024-08-06 2024-08-05
US Chemed Corp (CHE)
PrS Proposed sale
2,000
569.57
US$1,139,142 		2,000 569.57 US$1,139,142
2024-08-06 2024-08-05
US Chemed Corp (CHE)
S Sale
2,000 -1.9%
569.63
US$1,139,260 		2,000 -1.9% 569.63 US$1,139,260
2024-06-07 2024-06-06
US Chemed Corp (CHE)
S Sale
1,500 -1.4%
544.17
US$816,255 		1,500 -1.4% 544.17 US$816,255
2024-06-05 2024-06-06
US Chemed Corp (CHE)
PrS Proposed sale
1,500
547.00
US$820,500 		1,500 547.00 US$820,500
2024-05-17 2024-05-16
US Chemed Corp (CHE)
S Sale
4,000 -3.6%
567.54
US$2,270,160 		4,000 -3.6% 567.54 US$2,270,160
2024-05-16 2024-05-16
US Chemed Corp (CHE)
PrS Proposed sale
4,000
567.76
US$2,271,040 		4,000 567.76 US$2,271,040
2023-12-13 2023-12-11
US Chemed Corp (CHE)
S Sale
1,500 -1.3%
572.77
US$859,155 		1,500 -1.3% 572.77 US$859,155
2023-11-01 2023-10-31
US Chemed Corp (CHE)
S Sale
5,000 -4.2%
560.68
US$2,803,400 		5,000 -4.2% 560.68 US$2,803,400
2023-10-31 2023-10-31
US Chemed Corp (CHE)
PrS Proposed sale
5,000
562.24
US$2,811,200 		5,000 562.24 US$2,811,200
2023-08-07 2023-08-03
US Chemed Corp (CHE)
S Sale
4,000 -3.3%
516.43
US$2,065,720 		4,000 -3.3% 516.43 US$2,065,720
2023-05-08 2023-05-05
US Chemed Corp (CHE)
S Sale
4,000 -3.2%
549.34
US$2,197,360 		4,000 -3.2% 549.34 US$2,197,360
2023-05-05 2023-05-05
US Chemed Corp (CHE)
PrS Proposed sale
4,000
548.75
US$2,195,000 		4,000 548.75 US$2,195,000
2023-03-29 2023-03-28
US Chemed Corp (CHE)
S Sale
3,000 -2.5%
526.27
US$1,578,810 		3,000 -2.5% 526.27 US$1,578,810
2023-03-10 2023-03-09
US Chemed Corp (CHE)
S Sale
2,000 -1.6%
507.32
US$1,014,640 		2,000 -1.6% 507.32 US$1,014,640
2022-11-22 2022-11-21
US Chemed Corp (CHE)
S Sale
2,000 -1.6%
505.76
US$1,011,520 		2,000 -1.6% 505.76 US$1,011,520
2022-11-04 2022-11-03
US Chemed Corp (CHE)
S Sale
2,000 -1.6%
482.90
US$965,800 		2,000 -1.6% 482.90 US$965,800
2022-09-14 2022-09-13
US Chemed Corp (CHE)
S Sale
2,000 -1.6%
474.13
US$948,260 		2,000 -1.6% 474.13 US$948,260
2022-08-22 2022-08-18
US Chemed Corp (CHE)
S Sale
3,000 -2.3%
481.93
US$1,445,790 		3,000 -2.3% 481.93 US$1,445,790
2022-05-11 2022-05-10
US Chemed Corp (CHE)
S Sale
2,000 -1.5%
502.00
US$1,004,000 		2,000 -1.5% 502.00 US$1,004,000
2022-05-04 2022-05-02
US Chemed Corp (CHE)
S Sale
3,000 -2.3%
486.79
US$1,460,370 		3,000 -2.3% 486.79 US$1,460,370
2022-03-09 2022-03-08
US Chemed Corp (CHE)
S Sale
3,000 -2.2%
469.91
US$1,409,730 		3,000 -2.2% 469.91 US$1,409,730